Clinical Trial Update: Phase II Trial of Allovectin-7® for Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase II trial of Allovectin-7 for metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Allovectin-7

Snippet

Sponsor: Vical | Conditions: Melanoma, Metastatic Melanoma | Phase 2 | Status: COMPLETED